News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
648,167 Results
Type
Article (54275)
Company Profile (159)
Press Release (593733)
Multimedia
Podcasts (97)
Webinars (13)
Section
Business (178591)
Career Advice (2512)
Deals (32697)
Drug Delivery (121)
Drug Development (76781)
Employer Resources (159)
FDA (17140)
Job Trends (14285)
News (315067)
Policy (33849)
Tag
Academia (2699)
Academic (1)
Accelerated approval (7)
Adcomms (30)
Allergies (91)
Alliances (44889)
ALS (100)
Alzheimer's disease (1478)
Antibody-drug conjugate (ADC) (155)
Approvals (17097)
Artificial intelligence (294)
Autoimmune disease (27)
Automation (15)
Bankruptcy (342)
Best Places to Work (10902)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (100)
Bladder cancer (86)
Brain cancer (29)
Breast cancer (304)
Cancer (2398)
Cardiovascular disease (211)
Career advice (2109)
Career pathing (34)
CAR-T (170)
Cell therapy (466)
Cervical cancer (22)
Clinical research (62682)
Collaboration (850)
Company closure (2)
Compensation (580)
Complete response letters (29)
COVID-19 (2750)
CRISPR (47)
C-suite (259)
Cystic fibrosis (105)
Data (2354)
Decentralized trials (2)
Denatured (27)
Depression (54)
Diabetes (292)
Diagnostics (6071)
Digital health (20)
Diversity (7)
Diversity, equity & inclusion (42)
Drug discovery (120)
Drug pricing (131)
Drug shortages (31)
Duchenne muscular dystrophy (105)
Earnings (69812)
Editorial (47)
Employer branding (20)
Employer resources (143)
Events (95842)
Executive appointments (760)
FDA (18581)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (766)
Gene editing (115)
Generative AI (26)
Gene therapy (349)
GLP-1 (832)
Government (4499)
Grass and pollen (6)
Guidances (173)
Healthcare (18471)
Huntington's disease (25)
IgA nephropathy (32)
Immunology and inflammation (154)
Indications (29)
Infectious disease (2904)
Inflammatory bowel disease (145)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (100)
Interviews (456)
IPO (15460)
IRA (48)
Job creations (3787)
Job search strategy (1759)
Kidney cancer (11)
Labor market (37)
Layoffs (545)
Leadership (24)
Legal (8006)
Liver cancer (81)
Lung cancer (345)
Lymphoma (163)
Machine learning (9)
Management (56)
Manufacturing (345)
MASH (86)
Medical device (14142)
Medtech (14145)
Mergers & acquisitions (17827)
Metabolic disorders (801)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (2085)
NextGen: Class of 2025 (6284)
Non-profit (4228)
Now hiring (29)
Obesity (434)
Opinion (228)
Ovarian cancer (76)
Pain (102)
Pancreatic cancer (86)
Parkinson's disease (163)
Partnered (20)
Patents (255)
Patient recruitment (120)
Peanut (46)
People (54287)
Pharmaceutical (42)
Pharmacy benefit managers (24)
Phase I (19026)
Phase II (27373)
Phase III (21399)
Pipeline (1471)
Policy (179)
Postmarket research (2645)
Preclinical (7730)
Press Release (39)
Prostate cancer (113)
Psychedelics (36)
Radiopharmaceuticals (240)
Rare diseases (427)
Real estate (5467)
Recruiting (63)
Regulatory (23683)
Reports (34)
Research institute (2421)
Resumes & cover letters (413)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (139)
Series B (91)
Service/supplier (11)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (146)
Sponsored (33)
Startups (3438)
State (1)
Stomach cancer (16)
Supply chain (72)
Tariffs (59)
The Weekly (69)
Vaccines (800)
Venture capitalists (45)
Weight loss (302)
Women's health (34)
Worklife (20)
Date
Today (266)
Last 7 days (990)
Last 30 days (3499)
Last 365 days (32205)
2025 (12486)
2024 (34516)
2023 (38796)
2022 (49835)
2021 (54038)
2020 (52317)
2019 (44311)
2018 (33661)
2017 (32117)
2016 (31047)
2015 (34976)
2014 (28101)
2013 (23387)
2012 (25189)
2011 (25528)
2010 (23797)
Location
Africa (800)
Alabama (49)
Alaska (6)
Arizona (211)
Arkansas (13)
Asia (39139)
Australia (6532)
California (6329)
Canada (1882)
China (550)
Colorado (269)
Connecticut (292)
Delaware (153)
Europe (88697)
Florida (966)
Georgia (221)
Hawaii (1)
Idaho (52)
Illinois (570)
India (25)
Indiana (297)
Iowa (11)
Japan (177)
Kansas (98)
Kentucky (23)
Louisiana (10)
Maine (67)
Maryland (933)
Massachusetts (4732)
Michigan (209)
Minnesota (380)
Mississippi (2)
Missouri (83)
Montana (23)
Nebraska (22)
Nevada (68)
New Hampshire (65)
New Jersey (1773)
New Mexico (19)
New York (1772)
North Carolina (1014)
North Dakota (8)
Northern California (2810)
Ohio (200)
Oklahoma (12)
Oregon (33)
Pennsylvania (1385)
Puerto Rico (10)
Rhode Island (30)
South America (1183)
South Carolina (27)
South Dakota (1)
Southern California (2399)
Tennessee (105)
Texas (930)
United States (23742)
Utah (181)
Virginia (153)
Washington D.C. (66)
Washington State (561)
West Virginia (3)
Wisconsin (65)
648,167 Results for "morpheus medical s l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
BioNTech’s Ambitious PD-L1/VEGF Plans Currently Rely on Chinese Manufacturing
BNT327, a PD-L1/VEGF therapy, is still currently being manufactured in China, but BioNTech is working to establish a diversified supply chain, executives said during the company’s Q1 investor call.
May 5, 2025
·
3 min read
·
Tristan Manalac
Biotech Beach
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products
Irvine-based Biogennix, LLC an osteobiologics company specializing in bone graft products for fusion procedures, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its Agilon Moldable and Morpheus Moldable bone grafting products.
May 8, 2024
·
2 min read
Press Releases
EveryONE Medicines Announces Appointment of Michelle L. Mellion, MD, as Chief Medical Officer
April 16, 2025
·
4 min read
Press Releases
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
March 27, 2025
·
7 min read
Press Releases
Prolific Machines Announces the Completion of Optogenetic Bioproduction at 200L, Marking the World’s Largest Demonstration of Optogenetics to Date
April 17, 2025
·
3 min read
Press Releases
Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
February 19, 2025
·
9 min read
Press Releases
Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression
March 17, 2025
·
5 min read
Press Releases
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling
July 17, 2024
·
2 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Press Releases
Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
April 9, 2025
·
14 min read
1 of 64,817
Next
